Working with the Institute for Pediatric Innovation, Stanford School of Medicine and SRI International win a $1 million U.S. Food & Drug Administration grant for commercializing pediatric medical devices. The Food & Drug Administration awarded the MISTRAL Collaborative of SRI International and the Stanford University School of Medicine a $1 million grant to support the agency’s work to commercialize […]
Backers of the Ohio Third Frontier are mounting a campaign to market the state's biggest-ever economic development program to voters who will be asked to renew and expand the program in May.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.